Diferencia entre revisiones de «Eosinophilia»
| (No se muestra una edición intermedia del mismo usuario) | |||
| Línea 19: | Línea 19: | ||
==Evaluation== | ==Evaluation== | ||
*CBC with differential | |||
==Management== | ==Management== | ||
*Directed at underlying cause | |||
==Disposition== | ==Disposition== | ||
Revisión actual - 17:04 12 ene 2022
Background
- Defined usually as peripheral eosinophil count >0.5 x 109/L
- Eosinophils normally comprise <7% of total WBC count
Clinical Features
Differential Diagnosis
- Allergic reaction or other hypersensitivity/atopic state
- Urticaria, atopic dermatitis, asthma, drug reaction/hypersensitivity
- DRESS syndrome, drug-induced
- Parasitic infection
- Coccidioidomycosis and other fungal infections
- Malignancy (e.g. lymphoma, eosinophilic leukemia)
- Skin disorders (e.g. bullous pemphigoid, dermatitis herpetiformis)
- Adrenal insufficiency
- Connective tissue disease (e.g. Churg-Strauss syndrome)
- Interstitial nephritis
- Arsenic, gold toxicity
Evaluation
- CBC with differential
Management
- Directed at underlying cause